Brief: Hofseth Biocare Q1 Revenue NOK 52 Million
16/05/2024 07:00
May 16 (Reuters) - Hofseth Biocare Q1 adjusted free cash flow NOK -19.5 million. * Q1 EBITDA NOK -16.2 million
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering